Qilian International Holding - Wutah pendapatan triwulanan QLI

Simbol resmi perusahaan qlsyy.net (QLI)

Amid strict government regulation and the competition for public procurement, Qilian International relies on its licorice product production volumes and portfolio diversification. This quarterly revenue chart on GURU.Markets shows that the current parameter is -46.70. This trend reflects the impact of China's environmental oversight on capacity expansion within a closed B2B raw materials ecosystem.

QLI (Qilian International Holding Group Limited) riwayat Wutah pendapatan triwulanan saka 04.07.2022 nganti 17.08.2024

Rincian analitis perusahaan Qilian International Holding (QLI)

- kuotasi saiki lan rata-rata prakiraan nilai:
- data saldo dhuwit lan arus kas:
Analisis fundamental perusahaan:QLI - Qilian International Holding
Barang unggulan qlsyy.net

Comparative asset analysis requires an assessment of capital inflow rates, where this indicator measures the percentage deviation of current revenue from previous quarter figures to identify operational resilience. For Qilian International (QLI), which specializes in high-purity licorice extracts, the relative quarterly revenue change confirms the demand for organic raw materials among industrial partners, reflecting the brand's actual market value.

Pesaing langsung

HLN - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal kenvue.com|Verona Pharma (VRNA) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Jyong Biotech Limited (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Amneal Pharmaceuticals Inc AMRX|Wutah pendapatan triwulanan PRGO|Owah-owahan dodolan kuartal marang kuartal ALVO|Wutah pendapatan triwulanan LQDA (Liquidia Technologies)|Wutah pendapatan triwulanan Galapagos GLPG|ANI Pharmaceuticals Inc - Wutah pendapatan triwulanan|MNKD (MannKind Corp.) - Wutah dodolan kuartal marang kuartal|AMPH: Wutah pendapatan triwulanan|PCRX (Pacira BioSciences) - Wutah pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal ARS Pharmaceuticals Inc|Wutah dodolan triwulanan Theravance Biopharma, Inc. (TBPH)|Wutah dodolan triwulanan AQST (Aquestive Pharma)|SCPH - Tingkat wutah pendapatan sajrone kuartal|Wutah pendapatan triwulanan TECX (Tectonic Therapeutic, Inc.)|TNXP - Wutah dodolan triwulanan|China SXT Pharmaceuticals, Inc. - Wutah pendapatan triwulanan|EPRX - Wutah pendapatan triwulanan|BHST: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal ENTX (Entera Bio)|Wutah pendapatan kuartal marang kuartal MindWalk (HYFT)|Wutah pendapatan triwulanan ABVC BioPharma, Inc. (ABVC)|Wutah pendapatan kuartal marang kuartal Cumberland Corp CPIX|QNTM - Wutah dodolan triwulanan|FGEN - Wutah pendapatan kuartal marang kuartal|TELO - Wutah pendapatan triwulanan|Rani Therapeutics Inc (RANI) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan kuartal marang kuartal SNYR|Wutah pendapatan kuartal marang kuartal Rallybio Corp|Wutah pendapatan kuartal marang kuartal LEXX|Wutah pendapatan triwulanan PULM|PTHL: Dinamika pendapatan kuartal marang kuartal|Wutah pendapatan triwulanan APM (Aptorum Group Ltd)|LYRA - Wutah dodolan triwulanan|Impact BioMedical Inc - Wutah pendapatan triwulanan|Dinamika pendapatan kuartal marang kuartal TNFA|YCBD (cbdmd.com) - Wutah dodolan triwulanan|painreform.com - Tambahing pendapatan triwulanan|Wutah dodolan triwulanan CYTO|Wutah pendapatan kuartal marang kuartal LIPO|Wutah pendapatan kuartal marang kuartal optinose.com (OPTN)|PIRS (Pieris Pharma) - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Procaps Group S.A. PROC|Tingkat wutah dodolan sajrone kuartal petrospharma.com (PTPI)|ACELYRIN - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan TFFP (TFF Pharmaceuticals Inc.)